Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction
Top Cited Papers
Open Access
- 7 August 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 104 (6), 636-641
- https://doi.org/10.1161/hc3101.093701
Abstract
Background— Whereas survival after lytic therapy for myocardial infarction is strongly dependent on early administration, it is unknown whether the otherwise excellent outcomes in patients undergoi...Keywords
This publication has 22 references indexed in Scilit:
- Coronary Angioplasty with or without Stent Implantation for Acute Myocardial InfarctionNew England Journal of Medicine, 1999
- A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trialJournal of the American College of Cardiology, 1999
- Function and expression of endothelin-converting enzyme-1 in human vascular smooth muscleJournal of the American College of Cardiology, 1998
- A Prospective, Randomized Evaluation of Prophylactic Intraaortic Balloon Counterpulsation in High Risk Patients With Acute Myocardial Infarction Treated With Primary AngioplastyJournal of the American College of Cardiology, 1997
- Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: The primary angioplasty in myocardial infarction (PAMI) trialJournal of the American College of Cardiology, 1995
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 1994
- From myocardial salvage to patient salvage in acute myocardial infarction: The role of reperfusion therapyJournal of the American College of Cardiology, 1989
- THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTYThe Lancet, 1988
- Mycobacterium chelonaeWound Infections after Plastic Surgery Employing Contaminated Gentian Violet Skin-Marking SolutionNew England Journal of Medicine, 1987
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985